Randomized trial of induction immunosuppression with anti-IL2-R monoclonal antibody 33B3.1 and rabbit antithymocyte globulin following simultaneous pancreas and kidney transplantation.
Cantarovich
D
D
Service de Néphrologie et Immunologie Clinique Transplantation, Centre Hospitalier et Universitaire de Nantes, France.
Paineau
J
J
Le Mauff
B
B
Karam
G
G
Yaques
Y
Y
Hourmant
M
M
Dantal
J
J
Baatard
R
R
Soulillou
J P
JP
D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D016035:Pancreas Transplantation / Q000276:immunology*; D011817:Rabbits; D014511:Uremia / Q000601:surgery
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents